表达HBV前S2缺失突变体的小鼠出现肝肿大和肝细胞癌
该研究构建了表达天然存在的含33个核苷酸缺失的前S2突变蛋白(preΔS2)的Alb-preΔS2转基因小鼠,以探究其对肝癌发生的影响。随访30个月后,小鼠肝脏病理分为四组:G1仅慢性炎症;G2慢性炎症和纤维化;G3炎症、纤维化及肝肿大伴直肠脱垂(4-12%);G4肝肿大和自发肝细胞癌(12-15%)。早期(4月龄)即见内质网显著退化,8月龄诱导明显内质网应激和未折叠蛋白反应(UPR)的Atf6通路,同时涉及过氧化物酶体和内质网的甲羟戊酸和胆固醇生物合成代谢途径紊乱;20月龄及以上诱导UPR的PERK通路并激活Hippo转导子Yap。这些超微结构异常和代谢紊乱似乎共同促进了Alb-preΔS2小鼠的分子发病机制和肝癌发生。
要点
- preΔS2转基因小鼠30个月随访出现肝肿大和自发肝细胞癌(12-15%)。
- 早期(4月龄)见内质网显著退化,8月龄诱导内质网应激和Atf6通路。
- 20月龄及以上诱导PERK通路并激活Yap,与肝癌发生相关。
核心结论
- 表达preΔS2突变蛋白的转基因小鼠可发生肝肿大和自发肝细胞癌。
- 超微结构异常和代谢紊乱共同参与preΔS2相关肝癌的分子发病机制。
研究设计与样本
- 构建Alb-preΔS2转基因小鼠,表达含33个核苷酸缺失的天然pre-S2突变蛋白。
- 随访30个月,观察肝脏病理并进行机制研究。
主要发现
- 30个月随访后肝脏病理分为四组:G1仅慢性炎症;G2慢性炎症和纤维化;G3炎症、纤维化及肝肿大伴直肠脱垂(4-12%);G4肝肿大和自发肝细胞癌(12-15%)。
- 4月龄小鼠肝脏可见内质网显著退化。
- 8月龄诱导明显内质网应激和UPR的Atf6通路,同时甲羟戊酸和胆固醇生物合成代谢途径紊乱。
- 20月龄及以上诱导UPR的PERK通路并激活Hippo转导子Yap。
临床怎么用
- pre-S2缺失突变体可能作为HBV携带者肝硬化及肝癌风险的相关标志。
- 针对内质网应激和代谢通路的干预或为相关肝病和肝癌治疗提供方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatocellular carcinoma (HCC) is the most common form of liver cancer and has a poor prognosis and a low survival rate; its incidence is on the rise. Hepatitis B virus (HBV) infection is one of the main causes of HCC. A high prevalence of pre-S deletions of HBV surface antigen, which encompass T-cell and/or B-cell epitopes, is found in HBV carriers; antiviral therapy and viral immune escape may cause and select for these HBV mutants. In particular, the presence of pre-S2 deletion mutants is an important risk factor associated with cirrhosis and HCC. We generated Alb-preΔS2 transgenic mice that express a naturally occurring pre-S2 mutant protein containing a 33-nucleotide deletion (preΔS2); the aim was to investigate its effect on hepatocarcinogenesis. After 30 months of follow-up, the liver pathology of the mice fell into four groups: G1, chronic inflammation solely; G2, chronic inflammation and fibrosis; G3, inflammation, fibrosis, and hepatomegaly accompanied by rectal prolapse (4-12%); and G4, hepatomegaly and spontaneous HCC (12-15%). Striking degeneration of the endoplasmic reticulum (ER) was present in the mouse livers at an early stage (4 months old). At 8 months, overt ER stress and the Atf6 pathway of the unfolded protein response (UPR) were induced; at the same time, metabolic pathways associated with mevalonate and cholesterol biogenesis, involving the peroxisomes and the ER, were disturbed. At 20 months and older, the protein kinase RNA-like endoplasmic reticulum kinase (PERK) pathway of the UPR was induced and the Hippo transducer Yap was activated. Together, these ultrastructural aberrations and metabolic disturbance all seem to contribute to the molecular pathogenesis and hepatocarcinogenesis present in the Alb-preΔS2 mice. These findings may contribute to the development of therapies for the liver disorders and HCC associated with pre-S2 deletion mutations among HBV carriers. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
- Teng YC, Neo JC, Wu JC, et al. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice. J Pathol. 2017. PMID: 27868197. doi:10.1002/path.4850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。